| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Surgical Oncology [A. M. G., L. Z., W. W., D. B. E., P. J. C.], Tumor Biology [W. Z., P. J. C.], Gastrointestinal Medical Oncology and Digestive Diseases [J. L. A.], and Neuro-oncology [W. Z., S. R.], The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030
The tumor suppressor gene deleted in pancreatic cancer locus 4 (DPC4) is inactivated in about 50% of pancreatic adenocarcinomas. DPC4 was found to be homologous to Smad4 and may function as a transcription factor in the transforming growth factor ß (TGF-ß) receptor-mediated signal transduction pathway. We have investigated the role of DPC4 in the TGF-ß receptor-mediated signal transduction cascade in five human pancreatic cancer cell lines (Panc-1, MDAPanc-28, HS766T, Capan-1, and MiaPaCa-2). Our results demonstrate that the loss of responsiveness to TGF-ß-induced growth inhibition correlates with the loss of expression of DPC4. We have shown that TGF-ß induces p21waf1 expression in Panc-1 cells, whereas no induction of p21waf1 expression by TGF-ß was detected in the other four cell lines lacking either DPC4 expression or the TGF-ß type II receptor. No increase in p21waf1 mRNA stability was observed after treatment with TGF-ß, which suggests that the induction of p21waf1 in Panc-1 cells is transcriptionally regulated by TGF-ß. Our data also demonstrate that the expression of DPC4 is directly involved in TGF-ß-mediated induction of the 3TP-lux reporter gene, which contains a known TGF-ß-inducible plasminogen activator inhibitor promoter. These data suggest that: (a) TGF-ß-mediated induction of p21waf1 and subsequent growth inhibition require the expression of DPC4; (b) p21waf1 is a down-stream target gene of DPC4; and (c) transfection of the DPC4 gene restores the TGF-ß-inducible gene expression. Inactivation of the tumor suppressor gene DPC4 and other components of the TGF-ß signal cascades may abolish one of the key negative controls of cell proliferation in pancreatic adenocarcinomas.
1 Supported in part by a grant from the University Cancer Foundation of the University of Texas M. D. Anderson Cancer Center.
2 Present address: Department of General Surgery, The University of Arizona, 1501 N. Campbell Ave., Tucson, AZ 85724.
3 To whom requests for reprints should be address, at Department of Surgical Oncology, Box 107. The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030. Phone (713) 794-1030; Fax: (713) 794-4830; E-mail: paul_chiao@surg.mdacc.tmc.edu.
Received 5/22/97. Accepted 7/31/97.
This article has been cited by other articles:
![]() |
N. J. Gaspar, L. Li, A. M. Kapoun, S. Medicherla, M. Reddy, G. Li, G. O'Young, D. Quon, M. Henson, D. L. Damm, et al. Inhibition of Transforming Growth Factor beta Signaling Reduces Pancreatic Adenocarcinoma Growth and Invasiveness Mol. Pharmacol., July 1, 2007; 72(1): 152 - 161. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Ortiz-Zapater, S. Peiro, O. Roda, J. M. Corominas, S. Aguilar, C. Ampurdanes, F. X. Real, and P. Navarro Tissue Plasminogen Activator Induces Pancreatic Cancer Cell Proliferation by a Non-Catalytic Mechanism That Requires Extracellular Signal-Regulated Kinase 1/2 Activation through Epidermal Growth Factor Receptor and Annexin A2 Am. J. Pathol., May 1, 2007; 170(5): 1573 - 1584. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Takano, F. Kanai, A. Jazag, H. Ijichi, J. Yao, H. Ogawa, N. Enomoto, M. Omata, and A. Nakao Smad4 is Essential for Down-regulation of E-cadherin Induced by TGF-{beta} in Pancreatic Cancer Cell Line PANC-1 J. Biochem., March 1, 2007; 141(3): 345 - 351. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Baez, A. Cantor, S. Fonseca, M. Marcos-Martinez, L. A. Mathews, C. A. Muro-Cacho, and T. Munoz-Antonia Differences in Smad4 Expression in Human Papillomavirus Type 16-Positive and Human Papillomavirus Type 16-Negative Head and Neck Squamous Cell Carcinoma Clin. Cancer Res., May 1, 2005; 11(9): 3191 - 3197. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Wimmel, B Wiedenmann, and S Rosewicz Autocrine growth inhibition by transforming growth factor {beta}-1 (TGF{beta}-1) in human neuroendocrine tumour cells Gut, September 1, 2003; 52(9): 1308 - 1316. [Abstract] [Full Text] |
||||
![]() |
S. Fujioka, G. M. Sclabas, C. Schmidt, W. A. Frederick, Q. G. Dong, J. L. Abbruzzese, D. B. Evans, C. Baker, and P. J. Chiao Function of Nuclear Factor {kappa}B in Pancreatic Cancer Metastasis Clin. Cancer Res., January 1, 2003; 9(1): 346 - 354. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Biankin, A. L. Morey, C.-S. Lee, J. G. Kench, S. A. Biankin, H. C. Hook, D. R. Head, T. B. Hugh, R. L. Sutherland, and S. M. Henshall DPC4/Smad4 Expression and Outcome in Pancreatic Ductal Adenocarcinoma J. Clin. Oncol., December 1, 2002; 20(23): 4531 - 4542. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ramachandra, I. Atencio, A. Rahman, M. Vaillancourt, A. Zou, J. Avanzini, K. Wills, R. Bookstein, and P. Shabram Restoration of Transforming Growth Factor {beta} Signaling by Functional Expression of Smad4 Induces Anoikis Cancer Res., November 1, 2002; 62(21): 6045 - 6051. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Peng, J. B. Fleming, T. Breslin, A. M. Grau, S. Fojioka, J. L. Abbruzzese, D. B. Evans, D. Ayers, K. Wathen, T. Wu, et al. Suppression of Tumorigenesis and Induction of p15ink4b by Smad4/DPC4 in Human Pancreatic Cancer Cells Clin. Cancer Res., November 1, 2002; 8(11): 3628 - 3638. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Samatar, L. Wang, A. Mirza, S. Koseoglu, S. Liu, and C. C. Kumar Transforming Growth Factor-beta 2 Is a Transcriptional Target for Akt/Protein Kinase B via Forkhead Transcription Factor J. Biol. Chem., July 26, 2002; 277(31): 28118 - 28126. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kang, L. L. Ozbun, J. Angdisen, T. W. Moody, M. Prentice, B. A. Diwan, and S. B. Jakowlew Altered expression of G1/S regulatory genes occurs early and frequently in lung carcinogenesis in transforming growth factor-{beta}1 heterozygous mice Carcinogenesis, July 1, 2002; 23(7): 1217 - 1227. [Abstract] [Full Text] [PDF] |
||||
![]() |
A V Biankin, S A Biankin, J G Kench, A L Morey, C-S Lee, D R Head, R P Eckstein, T B Hugh, S M Henshall, and R L Sutherland Aberrant p16INK4A and DPC4/Smad4 expression in intraductal papillary mucinous tumours of the pancreas is associated with invasive ductal adenocarcinoma Gut, June 1, 2002; 50(6): 861 - 868. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Plath, M. Peters, K. Detjen, M. Welzel, Z. von Marschall, C. Radke, B. Wiedenmann, and S. Rosewicz Overexpression of pRB in Human Pancreatic Carcinoma Cells: Function in Chemotherapy-Induced Apoptosis J Natl Cancer Inst, January 16, 2002; 94(2): 129 - 142. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Biankin, J. G. Kench, A. L. Morey, C.-S. Lee, S. A. Biankin, D. R. Head, T. B. Hugh, S. M. Henshall, and R. L. Sutherland Overexpression of p21WAF1/CIP1 is an Early Event in the Development of Pancreatic Intraepithelial Neoplasia Cancer Res., December 1, 2001; 61(24): 8830 - 8837. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Venkatasubbarao, S. Ammanamanchi, M. G. Brattain, D. Mimari, and J. W. Freeman Reversion of Transcriptional Repression of Sp1 by 5 aza-2' Deoxycytidine Restores TGF-{beta} Type II Receptor Expression in the Pancreatic Cancer Cell Line MIA PaCa-2 Cancer Res., August 1, 2001; 61(16): 6239 - 6247. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zhang, K. Graziano, T. Pham, C. D. Logsdon, and D. M. Simeone Adenovirus-mediated gene transfer of dominant-negative Smad4 blocks TGF-{beta} signaling in pancreatic acinar cells Am J Physiol Gastrointest Liver Physiol, June 1, 2001; 280(6): G1247 - G1253. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kern, R. Hruban, M. A. Hollingsworth, R. Brand, T. E. Adrian, E. Jaffee, and M. A. Tempero A White Paper: The Product of a Pancreas Cancer Think Tank Cancer Res., June 1, 2001; 61(12): 4923 - 4932. [Full Text] [PDF] |
||||
![]() |
T. Plath, K. Detjen, M. Welzel, Z. von Marschall, D. Murphy, M. Schirner, B. Wiedenmann, and S. Rosewicz A Novel Function for the Tumor Suppressor p16INK4a: Induction of Anoikis via Upregulation of the {alpha}5{beta}1 Fibronectin Receptor J. Cell Biol., September 18, 2000; 150(6): 1467 - 1478. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. de Caestecker, E. Piek, and A. B. Roberts Role of Transforming Growth Factor-{beta} Signaling in Cancer J Natl Cancer Inst, September 6, 2000; 92(17): 1388 - 1402. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Schwarte-Waldhoff, O. V. Volpert, N. P. Bouck, B. Sipos, S. A. Hahn, S. Klein-Scory, J. Luttges, G. Kloppel, U. Graeven, C. Eilert-Micus, et al. Smad4/DPC4-mediated tumor suppression through suppression of angiogenesis PNAS, August 15, 2000; 97(17): 9624 - 9629. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Bruns, C. C. Solorzano, M. T. Harbison, S. Ozawa, R. Tsan, D. Fan, J. Abbruzzese, P. Traxler, E. Buchdunger, R. Radinsky, et al. Blockade of the Epidermal Growth Factor Receptor Signaling by a Novel Tyrosine Kinase Inhibitor Leads to Apoptosis of Endothelial Cells and Therapy of Human Pancreatic Carcinoma Cancer Res., June 1, 2000; 60(11): 2926 - 2935. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.-J. Park, J.-I. Park, D.-S. Byun, J.-H. Park, and S.-G. Chi Mitogenic Conversion of Transforming Growth Factor-{beta}1 Effect by Oncogenic Ha-Ras-induced Activation of the Mitogen-activated Protein Kinase Signaling Pathway in Human Prostate Cancer Cancer Res., June 1, 2000; 60(11): 3031 - 3038. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Cook and R. Urrutia TIEG proteins join the Smads as TGF-beta -regulated transcription factors that control pancreatic cell growth Am J Physiol Gastrointest Liver Physiol, April 1, 2000; 278(4): G513 - G521. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Wilentz, G. H. Su, J. L. Dai, A. B. Sparks, P. Argani, T. A. Sohn, C. J. Yeo, S. E. Kern, and R. H. Hruban Immunohistochemical Labeling for Dpc4 Mirrors Genetic Status in Pancreatic Adenocarcinomas : A New Marker of DPC4 Inactivation Am. J. Pathol., January 1, 2000; 156(1): 37 - 43. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Rodeck, T. Nishiyama, and A. Mauviel Independent Regulation of Growth and SMAD-mediated Transcription by Transforming Growth Factor {beta} in Human Melanoma Cells Cancer Res., February 1, 1999; 59(3): 547 - 550. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Inoue, T. Imamura, Y. Ishidou, M. Takase, Y. Udagawa, Y. Oka, K. Tsuneizumi, T. Tabata, K. Miyazono, and M. Kawabata Interplay of Signal Mediators of Decapentaplegic (Dpp): Molecular Characterization of Mothers against dpp, Medea, and Daughters against dpp Mol. Biol. Cell, August 1, 1998; 9(8): 2145 - 2156. [Abstract] [Full Text] |
||||
![]() |
J. R. Howe, S. Roth, J. C. Ringold, R. W. Summers, H. J. Järvinen, P. Sistonen, I. P. Tomlinson, R. S. Houlston, S. Bevan, F. A. Mitros, et al. Mutations in the SMAD4/DPC4 Gene in Juvenile Polyposis Science, May 15, 1998; 280(5366): 1086 - 1088. [Abstract] [Full Text] |
||||
![]() |
S. Zhou, P. Buckhaults, L. Zawel, F. Bunz, G. Riggins, J. Le Dai, S. E. Kern, K. W. Kinzler, and B. Vogelstein Targeted deletion of Smad4 shows it is required for transforming growth factor beta and activin signaling in colorectal cancer cells PNAS, March 3, 1998; 95(5): 2412 - 2416. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Puente, N. Saint-Laurent, J. Torrisani, C. Furet, A. V. Schally, N. Vaysse, L. Buscail, and C. Susini Transcriptional Activation of Mouse sst2 Somatostatin Receptor Promoter by Transforming Growth Factor-beta . INVOLVEMENT OF Smad4 J. Biol. Chem., April 13, 2001; 276(16): 13461 - 13468. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Ahmed, R. A. Alcock, D. Chendil, S. Dey, A. Das, K. Venkatasubbarao, M. Mohiuddin, L. Sun, W. E. Strodel, and J. W. Freeman Restoration of Transforming Growth Factor-beta Signaling Enhances Radiosensitivity by Altering the Bcl-2/Bax Ratio in the p53 Mutant Pancreatic Cancer Cell Line MIA PaCa-2 J. Biol. Chem., January 11, 2002; 277(3): 2234 - 2246. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |